WallStreetZenWallStreetZen

NASDAQ: PYPD
Polypid Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PYPD

Based on 1 analyst offering 12 month price targets for Polypid Ltd

Min Forecast
$13.00+203.03%
Avg Forecast
$13.00+203.03%
Max Forecast
$13.00+203.03%

Should I buy or sell PYPD stock?

Based on 1 analyst offering ratings for Polypid Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although PYPD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates PYPD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their PYPD stock forecasts and price targets.

PYPD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-21

1 of 1

Forecast return on equity

Is PYPD forecast to generate an efficient return?

Company
294.44%
Industry
87.23%
Market
180.82%
PYPD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PYPD forecast to generate an efficient return on assets?

Company
144.84%
Industry
26.37%
PYPD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PYPD earnings per share forecast

What is PYPD's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$1.59-175.88%
Avg 2 year Forecast
-$1.28-161.32%
Avg 3 year Forecast
-$0.41-119.52%

PYPD revenue forecast

What is PYPD's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$9.8M
Avg 3 year Forecast
$25.2M

PYPD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PYPD$4.29$13.00+203.03%Buy
NRXS$6.25$13.00+108.00%Buy
CGTX$0.89$4.00+349.44%Strong Buy
MAIA$1.25N/AN/A
ATRA$8.38$11.50+37.23%Buy
View Top Biotech Stocks

Polypid Stock Forecast FAQ

Is Polypid Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PYPD) stock is to Buy PYPD stock.

Out of 1 analyst, 0 (0%) are recommending PYPD as a Strong Buy, 1 (100%) are recommending PYPD as a Buy, 0 (0%) are recommending PYPD as a Hold, 0 (0%) are recommending PYPD as a Sell, and 0 (0%) are recommending PYPD as a Strong Sell.

If you're new to stock investing, here's how to buy Polypid stock.

What is PYPD's earnings growth forecast for 2026-2028?

(NASDAQ: PYPD) Polypid's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.91%.

Polypid's earnings in 2026 is -$34,169,000.On average, 6 Wall Street analysts forecast PYPD's earnings for 2026 to be -$28,867,906, with the lowest PYPD earnings forecast at -$32,539,654, and the highest PYPD earnings forecast at -$23,128,185. On average, 6 Wall Street analysts forecast PYPD's earnings for 2027 to be -$23,330,249, with the lowest PYPD earnings forecast at -$38,284,837, and the highest PYPD earnings forecast at -$16,055,930.

In 2028, PYPD is forecast to generate -$7,427,233 in earnings, with the lowest earnings forecast at -$7,135,969 and the highest earnings forecast at -$7,645,681.

What is PYPD's revenue growth forecast for 2026-2028?

(NASDAQ: PYPD) Polypid's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.72%.

Polypid's revenue in 2026 is $0.On average, 6 Wall Street analysts forecast PYPD's revenue for 2026 to be $0, with the lowest PYPD revenue forecast at $0, and the highest PYPD revenue forecast at $0. On average, 6 Wall Street analysts forecast PYPD's revenue for 2027 to be $178,872,524, with the lowest PYPD revenue forecast at $98,119,571, and the highest PYPD revenue forecast at $252,307,468.

In 2028, PYPD is forecast to generate $458,631,626 in revenue, with the lowest revenue forecast at $435,294,096 and the highest revenue forecast at $477,855,053.

What is PYPD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: PYPD) forecast ROA is 144.84%, which is higher than the forecast US Biotechnology industry average of 26.37%.

What is PYPD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PYPD price target, the average PYPD price target is $13.00, with the highest PYPD stock price forecast at $13.00 and the lowest PYPD stock price forecast at $13.00.

The Wall Street analyst predicted that Polypid's share price could reach $13.00 by Jul 21, 2027. The average Polypid stock price prediction forecasts a potential upside of 203.03% from the current PYPD share price of $4.29.

What is PYPD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: PYPD) Polypid's current Earnings Per Share (EPS) is $2.09. On average, analysts forecast that PYPD's EPS will be -$1.59 for 2026, with the lowest EPS forecast at -$1.79, and the highest EPS forecast at -$1.27. On average, analysts forecast that PYPD's EPS will be -$1.28 for 2027, with the lowest EPS forecast at -$2.10, and the highest EPS forecast at -$0.88. In 2028, PYPD's EPS is forecast to hit -$0.41 (min: -$0.39, max: -$0.42).

What is PYPD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: PYPD) forecast ROE is 294.44%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.